Johanna Lempainen Selected Research

Johanna Lempainen Research Topics

15	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 12/2010
5	COVID-19 01/2022 - 01/2021
4	Infections 01/2022 - 01/2019
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2017
2	Insulinoma 01/2019 - 06/2013
1	Coinfection 01/2022
1	Breakthrough Infections 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Reinfection 01/2021
1	Otitis Media 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 07/2020
1	Pharyngitis (Sore Throat) 01/2017

13	AutoantibodiesIBA 01/2022 - 12/2010
6	Insulin (Novolin)FDA Link 11/2020 - 04/2012
5	VaccinesIBA 01/2022 - 01/2021
5	1,3-di(4-imidazolinophenoxyl)propaneIBA 11/2020 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2015
4	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 11/2020 - 06/2013
3	AntibodiesIBA 01/2022 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2020
3	BNT162 VaccineIBA 01/2022 - 01/2022
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2022
3	Staphylococcal Protein A (Protein A)IBA 01/2022 - 01/2017
3	mRNA VaccinesIBA 01/2022 - 01/2021
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 06/2013
3	AntigensIBA 11/2020 - 06/2013
3	HLA-DR Antigens (HLA-DR)IBA 11/2020 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2020
2	Neutralizing AntibodiesIBA 01/2022 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2021
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	NucleoproteinsIBA 01/2022
1	CytokinesIBA 01/2022
1	Interferon Type IIBA 01/2021
1	Zinc Transporter 8IBA 11/2020
1	Immunoglobulin G (IgG)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Genetic Markers (Genetic Marker)IBA 01/2017
1	InterferonsIBA 01/2017

1	Personal Protective Equipment 01/2022